Reistone Biopharma Company Limited is a clinical stage biopharmaceutical company focused on developing novel medicines for life threatening autoimmune diseases. Developing therapies for diseases requires new approaches and strong collaboration between scientists, industry, regulators and patient groups. Reistone was forged from the company’s close collaborations with key stakeholders and leading pharmaceutical companies dedicated to transforming new biotechnology insights into breakthrough medicine for significant unmet medical needs in China as well globally.